Several reports describe that the explant culture of the trabecular bone after collagenase treatment produces mesenchymal stem cells (MSCs). However, the suspended cells had not been intensively examined concerning MSCs. We hypothesized the cells would acquire the properties of MSCs during their expansion and therefore compared them to marrow aspirate-derived MSCs. Human trabecular bones were washed, digested, filtered, and expanded clonally for 14 days. Their proliferation ability (n=9) and differentiation potentials for chondrocyte, adipocyte, and osteoblast (n=6) were similar with those of marrow aspirate-derived MSCs. Epitope and mRNA analysis revealed some differences in both type of cells, which disappeared with expansion and subcultivation. A mixed population of CR cells had similar differentiation potentials with CR clone, CD31 positive fraction, and osteoblastic cells. For quantitative study, trabecular bone and bone marrow were harvested by single aspiration using a biopsy needle (n=16). Though the total nucleated cell number harvested was almost similar, the colony forming efficiency of CR cells was approximately 100-fold higher than that of BM cells and more than 1 million CR cells could be obtained in 14 days from all donors. Enzymatically released cells from trabecular bone became virtually identical to marrow aspirate-derived MSCs, demonstrating that a trabecular bone fragment can be an alternative source of MSCs.
Introduction
For personal use only. on . by guest www.bloodjournal.org From Human cells derived from trabecular bones have been used for many years in the study of bone cell biology. [1] [2] [3] [4] [5] Recently, Tuan et al. [6] [7] [8] and Seuwen et al. 9 reported that human trabecular bone is a good source of mesenchymal stem cells (MSCs) with the characteristics of self-renewal and multilineage differentiation potential. To isolate MSCs from trabecular bones, they digested human trabecular bone with collagenase to release cells, referred to as collagenase-released (CR) cells. Then, they did explant cultures of the remaining bare bone fragments and harvested MSCs that were derived from the trabecular bones. CR cells were first mentioned by Robey and Termine to as part of a study of osteoblast metabolism in vitro. 1 However, the CR cells were not examined intensively because the CR cell cultures showed a high level of type III collagen, which they simply regarded as fibroblastic contamination. 1 Also, Tuan et al. described contamination by foreign marrow cells, especially fibroblasts, often predominated in the CR cell cultures. 8 Furthermore, collagenase pretreatment followed by extensive washing resulted in trabecular bone fragments completely devoid of surface-adherent cells, with all soft-tissue elements removed. 8 Therefore, until now the CR cells have been thought to be a poor source of MSCs.
A large body of literature has developed on MSCs derived from bone marrow aspirate, the vascular sinuses and on the abluminal side there is a thick adventitial cell layer, which contains mainly reticular, adipocytic and smooth muscle cells. 11 No specific antigens have been described that For personal use only. on . by guest www.bloodjournal.org From associate the developmental potential of MSCs with a specific phenotypic trait. Therefore, it is not possible at this time to determine the anatomical location of MSCs within bone marrow. Several laboratories have isolated monoclonal antibodies, including Stro-1 12 and SB-10 13 that are immuno-reactive against stromal cells cultured in vitro. Recently, Stro-1 was shown to bind to the endothelial cells in a variety of tissues. 14 SB-10 was also reported to correspond to ALCAM, 15 which is expressed on endothelial cells as well as mesenchymal stem cells. 16 This suggests that the medullary vascular network represents the closest in vivo approximation to the MSCs. 17 We hypothesized that CR cells contained the cells derived from the medullary vascular network. Furthermore, the CR cells contain bone lining cells and adipocytes, which are other origins of MSCs.
In this pioneer study, we have quantitatively compared properties of the cells released from the trabecular bone by collagenase treatment to the bone marrow stromal cells obtained from marrow aspirates. The two populations of cells were found to be virtually identical, except initially for the expression of two surface markers, which may indicate the presence of endothelial and bone lining cells in the CR population. Contrary to previous reports, obtaining CR cells is a simple and high-yield procedure for isolating primary mesenchymal progenitor cells from a small piece of trabecular bone. ACL reconstructions, and the elderly patients had total knee arthroplasties. In the young patients, trabecular bone fragments were obtained with a curet from the tibia from the new route for the reconstructed ligament. In the elderly patients, trabecular bone fragments were curettaged at the resected proximal tibia and collected. Bone marrow was obtained from the tibia by only one aspiration with an 18-guage needle fastened to a 20 ml syringe.
Materials and methods

Trabecular bone fragments and bone marrow aspirates
In addition, both human trabecular bones and bone marrow aspirates were harvested from the tibia by single aspiration using Jamshidi Bone Marrow Biopsy/ Aspiration Needle (Allegiance Healthcare Corporation, McGaw Park, IL, USA) during the knee operations of 16 donors; 8 young patients (23 ± 3 y.o.) and 8 elderly patients (72 ± 8 y.o.). The study was approved by an Institutional Review Board and informed consents were obtained from all study subjects.
Isolation and cultures of CR cells and BM cells
Trabecular bone fragments were weighed and washed thoroughly with PBS to remove hematopoietic cells. The fragments were then digested in a collagenase solution [3 mg/ml collagenase D (Roche Diagnostics, Mannheim, Germany) in MEM (Invitrogen, Carlsbad, CA, USA)] at 37°C. After 3 hours, digested cells (CR cells) were filtered through a 70 µm nylon filter (Becton Dickinson, Franklin Lakes, NJ, USA) The digested cells were plated in a culture dish (Nalge Nunc International, Rochester, NY, USA) in complete culture medium: MEM containing 20% fetal bovine serum (FBS; Invitrogen; lot selected for rapid growth of MSCs), 100 units/ml penicillin (Invitrogen), 100 µg/ml streptomycin (Invitrogen), and 250 ng/ml amphotericin B (Invitrogen). Also, 100 µl of bone marrow aspirate were plated in a culture dish in complete culture medium. Both cells were incubated at 37°C with 5%
For personal use only. on October 3, 2017. by guest www.bloodjournal.org From humidified CO 2 . After 24 hours, the adherent cells were further washed with PBS and complete culture medium was added every 3 or 4 days. After 14 days of initial plating, the cells were harvested with 0.25% trypsin and 1mM EDTA (Invitrogen) for 5 min at 37°C (Passage 0), counted with a hemocytometer, and replated at 50 cells/cm2 in a 145-cm2 culture dish. After an additional 14 days of growth, the cells were harvested, and counted on a hemocytometer to determine the fold increase at Passage 1. To cryopreserve the cells, they were resuspended at a concentration of 1×10 6 
Assay of colony-forming efficiency (CFU assay)
The CR cells and BM cells at Passage 1 were plated at 100 cells per 60-cm2 dish, incubated for 14 days, and stained with 0.5% Crystal Violet in methanol for 5 minutes. The cells were washed twice with distilled water, and the number of colonies per dish was counted. Colonies less than 2 mm in diameter and faintly stained colonies were ignored.
Epitope profile
The CR cells and BM cells at Passage 0 were harvested 14 days after plating. One million 
In vitro Chondrogenesis
Two hundred thousand cells were placed in a 15-ml polypropylene tube (Becton Dickinson) and centrifuged at 450 X g for 10 min. The pellet was cultured at 37°C with 5% CO2 in 400µl of chondrogenic media that contained 500 ng/ml bone morphogenetic protein-2 (BMP-2; R&D Systems.
Minneapolis, MN, USA) in high-glucose Dulbecco's modified Eagle's medium (Invitrogen Corp) supplemented with 10 ng/ml transforming growth factor-3 (TGF-3), 10 -7 M dexamethasone (Sigma-Aldrich Corp. St. Louis, MO, USA), 50 µg/ml ascorbate-2-phosphate, 40 µg/ml proline, 100 µg/ml pyruvate, and 50 mg/ml ITS+Premix (Becton Dickinson; 6.25 µg/ml insulin, 6.25 µg/ml transferrin, 6.25 ng/ml selenious acid, 1.25 mg/ml BSA, and 5.35 mg/ml linoleic acid). The medium was replaced every 3 to 4 days for 21 days. 19 For microscopy, the pellets were embedded in paraffin, cut into 5-µm sections, and stained with Toluidine Blue. For type II collagen detection, sections were pre-digested proteinase K enzyme for 15 min. Then, sections were incubated with primary antibodies : mouse monoclonal antibody to human type II collagen (Daiichi Fine Chemical, Toyama, Japan) for 1 hour at room temperature. Sections were incubation for 30min with biotinylated secondary antibodies.
Immunostaining was detected by Vector ABC kit Anti-mouse IgG (H+L), made in horse (Vector Laboratories, Burlingame, CA, USA). Counterstaining was performed with Mayer-hematoxylin.
Adipogenesis in a colony-forming assay
One hundred CR cells or BM cells were plated in 60cm 2 dishes and cultured in complete 
Calcification in a colony-forming assay
One hundred CR cells and BM cells were plated in 60cm 2 dishes and cultured in complete media for 14 days. The medium was switched to calcification medium that consisted of complete medium supplemented with 10 -9 M dexamethasone (Sigma-Aldrich Corp), 20 mM -glycerol phosphate (Wako), and 50 µg/ml ascorbate-2-phosphate for additional 21 days. These dishes were stained with fresh Alizarin Red solution, and the number of alizarin red-positive colonies was counted. Colonies less than 2 mm in diameter or faint colonies were ignored. The same calcification cultures were subsequently stained with crystal Violet, and the total number of cell colonies was counted.
RNA Collection
Total RNA was prepared from 40 million CR cells just after collagenase digestion, or 1 million CR cells and BM cells 14 days after plating Passage 0, by extraction using the RNAqueous Kit (Ambion,
Austin, TX).
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Reverse transcription (RT)-PCR analysis
RNA was converted to cDNA and amplified by the Titan One Tube RTPCR System (Roche Diagnostics) according to the manufacturer's recommendations. RT was performed by a 30-min incubation at 50°C, followed by a 2-min incubation at 94°C to inactivate the RT. PCR amplification of the resulting cDNAs was performed under the following conditions: 35 cycles of 94°C for 30 s, 58°C for 45 s, and 68°C for 45 s, in which the 68°C step was increased by 5 s every cycle after 10 cycles. The reaction products were resolved by electrophoresis on a 1.5 % agarose gel and visualized with ethidium bromide.
PCR primers are as follows: 
Real Time PCR analysis
Quantitative PCRs were performed in a LightCyclerTM instrument (Roche Diagnostics, Basel, Switzerland). cDNA was synthesized from total RNA using SuperScriptTM III Reverse Transcriptase (Invitrogen) according to the manufacturer's protocol. cDNAs were mixed with LightCyclerTM FastStart DNA Master SYBR Green I and LightCyclerTM Primer Set; CBFA1, PPAR-and -Actin (Search-LC GmbH, Heidelberg, Germany). After initial denaturation step (95°C for 10 min) amplification was performed for 35 cycles (95°C for 1 sec, 56°C for 30 sec, 72°C for 30 sec). 
Statistical analysis
Two-factor ANOVA and Student's t-test were used for assessing differences. A value of p<0.05 was considered significant.
Results
Culture of CR cells and BM cells
Trabecular bone fragments obtained were red in color ( Figure 1A , left) due to the presence of hematopoietic cells, which were observed around the trabecula ( Figure 1B ) and in the blood vessels ( Figure 1C ). After washing thoroughly with PBS, the fragments looked yellowish due to removal of the hematopoietic cells ( Figure 1A, center) . Bone lining cells ( Figure 1D 
Characterization of CR Cells and BM cells
We examined surface epitopes of the CR and BM cells 14 days after primary culture. Of the 14 antibodies examined, both CR cells and BM cells were negative for CD31, CD34, CD45, CD117(c-kit), showed low level of CD10, 22 Flk-1 (VEGF Receptor 2), 23 
Proliferative potential of CR cells and BM cells
At Passage 1, both CR cells and BM cells had similar proliferation capabilities ( Figure 3A) .
Interestingly, both CR cells and BM cells in young donors proliferated at a greater rate than those in elderly donors. Although some donor variation existed, there were no significant differences seen in the colony forming efficiencies of CR cells and BM cells ( Figure 3B ). The difference of proliferation ability between young and elderly donors was due to cell number per colony in both CR cells and BM cells ( Figure 3C 
Differentiation potential of CR cells and BM cells
To compare chondrogenic potential of CR cells and BM cells, the cells were pelleted and 
MESENCHYMAL STEM CELLS FROM HUMAN TRABECULAR BONE -18 -
To determine the adipocyte differentiation potential, adipogenesis in a colony-forming assay was performed. 30 The number of colonies that accumulated lipids was evaluated 21 days after adipogenesis induction. First, adipocyte colonies were stained with Oil Red-O; then, the same dishes were stained with Crystal Violet and the ratio of Oil Red-O positive colonies to the total number of colonies was calculated for each dish ( Figure 5 ).
MESENCHYMAL STEM CELLS FROM HUMAN TRABECULAR BONE -19 -
CR cells were cultured in calcification medium and an increase in alkaline phosphatase, bone sialoprotein, and osteocalcin expression was confirmed by reverse transcription-PCR ( Figure 6A ). Also, sufficient levels of alkaline phosphatase activity were detected in both CR cells and BM cells cultured in calcification medium ( Figure 6B) . Furthermore, the ratio of Alizarin-Red positive colonies to the total number of colonies was analyzed in a method similar to the Adipogenesis assay ( Figure 6C 
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Although there were differences in the differentiation potentials in some donors, there was no significant differences between the CR and BM cells for chondrogenesis ( Figure 4D 
MESENCHYMAL STEM CELLS FROM HUMAN TRABECULAR BONE -21 -(
Figure 5B), or osteogenesis ( Figure 6C ) by a two-factor ANOVA. Also, there were no significant differences between young and elderly donors.
Progenitor assay
To convincingly show that CR cells come from an MSC progenitor, we expanded CR and BM cells cells at Passage 0 clonally, and then differentiated the offspring into adipocytes and osteoblasts without replating. Oil red-O and Alizarin-Red positive colony forming efficiency were 30 to 40% in both CR cells and BM cells and in both young and elderly donors ( Figure 7A , B).
Mixed and purified populations of CR cells
To compare CR cells to better defined populations, we prepared clones and CD31 positive fractions of CR cells. Among 5 clones, 3 clones had a proliferation potential of more than 30 doublings For personal use only. on October 3, 2017. by guest www.bloodjournal.org From
Trabecular bone harvested with biopsy needle
In consideration of the clinical use of CR cells, trabecular bone was harvested by single aspiration using a Jamshidi Bone Marrow Biopsy/ Aspiration Needle. Bone marrow was also collected by single aspiration using same biopsy needle. Nucleated cells were plated as described in the methods section and expanded for 14 days. Though the total nucleated cell number harvested was almost similar in CR cells and BM cells, colony forming efficiency of CR cells was approximately 100-fold higher than that of BM cells in both young and elderly donors ( Table 2) . We were able to harvest 5.4 ± 2.9 x 10 6 CR cells from young donors and 7.4 ± 6.0 x 10 6 CR cells from elderly donors. Importantly, more than 1 million CR cells could be obtained from all donors by single aspiration using biopsy needle ( Figure 9 ).
Discussion
In this work, we have compared the properties of mesenchymal progenitors in cultures derived from human bone marrow (BM cells) and from a suspension of cells derived from the soft connective tissue and bone lining after collagenase treatment of trabecular bone fragments (CR cells).
Results revealed that the morphology, proliferation, expression of molecular differentiation markers, and differentiation potential were very similar in both type of cells. There were, however, some differences in the properties of BM -and CR-passage 0 cells, which tend to disappear with subcultivation.
Trabecular bone has been known as a source of primary osteoblasts for years and there seem to be two techniques for isolation performed as part of osteoblast research. In the first, the trabecular bone fragments are digested by collagenase solutions, the supernatant fraction (CR cells) is removed, and the remaining bone fragments are cultured. 1, 5, 18 In the second protocol, the trabecular 2, 3, 4 We digested the trabecular bone fragments using collagenase solutions, discarded the remaining bone fragments, and cultured the supernatant fraction. Therefore, our preparation of CR cells is different from conventional preparations of trabecular bone-derived osteoblasts as explant culture.
Tuan et al. [6] [7] [8] reported that explant cultures of collagenase pretreated trabecular bone fragment, known as isolation technique for osteoblasts, 1,5,18 gave rise to multipotential mesenchymal progenitor cells. They maintained explant cultures for 28 days and harvested approximately 2 million cells per gram of bone chips. 7 Their cells reached 70-80% confluence, while our cells were maintained for 14 days at clonal density when the cells were harvested, so two methods cannot be strictly compared.
However, we harvested an average of 89 million cells from young and 103 million cells from elderly donors per gram of trabecular bone. Furthermore, the CR cells could be proliferated over 100-fold in 14 days. Therefore, this study introduces a higher-yield procedure for isolating MSCs than the previous method.
Our PCR study showed that the expression of osteoblast phenotypic genes, CBFA1, Osterix, and adipocyte phenotypic genes, PPAR , FABP4 decreased during the expansion of the CR cells. On For
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Interestingly, CD54 (ICAM-1) and CD106 (VCAM-1) expression levels in the CR cells were higher than in the BM cells, although these two cell populations had similar pattern of the other cell surface antigens. ICAM-1 and VCAM-1 are expressed on endothelial cells, 31 adipose tissue-derived stromal cells, 32 and osteoblasts. 33 VCAM-1 is also expressed on bone marrow stromal reticular cells. 34 These results suggest that the higher expression of ICAM-1 and VCAM-1 on the CR cells reflect the origin of the cells. According to our histological results (Figure 1) , bone lining cells, endothelial cells, and adipocytes were not observed in the remaining trabecular bone fragments after collagenase digestion.
This suggests that CR cells originated from these cells. Possibly CR cells also contain marrow reticular cells, which can't be detected without electron microscopy. 34 The CR cells and the BM cells were identical except for expression of two surface markers for mature endothelial cells and osteoblasts but that these differences were lost in the next cell passage. This suggests that CR cells de-differentiate and lose the phenotypes of the origin and become identical to BM cells with culture.
In our study, there were no obvious differences between young and elderly donors for yields of the cells at Passage 0, the colony forming efficiency at Passage 0 cells, surface cell antigens, progenitors of adipocyte and osteoblast, or their chondrocyte, adipocyte, and calcification differentiation potential. However, proliferation ability of Passage 1 decreased with aging due to decrease of cell number per a colony. Some researchers have reported that aging did not affect colony forming efficiency and proliferative capacity, 35 adipogenesis, and calcification. 36 To the contrary, others have reported that aging affected the initial yield 37 and proliferative capacity 38 of mesenchymal stem cells. Apparently, the disagreement is due to the differences in the sample isolation and expansion.
We quantitatively evaluated the chondrogenesis potential of a population of MSCs as pellet Fully differentiated adipocytes have a poor proliferation potential and the cells cannot form single cell derived colonies. 40 Therefore, our result of CFU for adipogenesis was not due to contamination of fully differentiated adipocytes.
We showed that mixed population of CR cells had similar potentials for chondrocyte-, adipocyte-, and osteoblast-differentiation with CR clone and CD31 positive fraction of CR cells. Despite the great interest in MSCs, the cells are still poorly characterized. Part of the difficulty lies in the subtle changes the cells undergo as they are expanded in culture. 10 Although clonal colony and purified population of MSCs are readily prepared, the cells rapidly become heterogeneous as they expand so that they contain subpopulations of early progenitors and more differentiated cells. We have already
shown that the early progenitors are quickly lost during expansion unless the cells were maintained at very low densities and the culture conditions carefully monitored. 30 It has not been established, however, which subpopulations provide the most robust differentiation. Figure 3A , the CR cells can be expanded more than 100-fold in 14 days. This means a large enough amount of trabecular bone can be collected with biopsy needle in the outpatient setting under local anesthesia.
In comparison of BM cells, we collected bone marrow together with the same biopsy needle and found that, though the total nucleated cell number harvested was almost similar in CR cells and BM cells, colony forming efficiency of BM cells was approximately 100-fold lower compared to CR cells in both young and elderly donors. Large amounts of bone marrow are aspirated with more invasions.
There is a report that small volume aspirates yielded more nucleated cells than large volume aspirates. 42 Failure to obtain sufficient amount of aspirates from bone marrow were reported in elderly patients and those with hematological disorders such as aplastic anemia. 43 These data suggest that it is not always possible to collect enough bone marrow from all donors by single aspiration using a biopsy needle to ensure the harvest of a sufficient number of MSCs. We propose that a trabecular bone fragment can be an alternative source of mesenchymal stem cells for both basic research and clinical use. For personal use only. on October 3, 2017. by guest www.bloodjournal.org From
